Since March 2020, the S&P 500 has achieved a total return of 97.5%. However, Boston Scientific has performed even better, rising 176% to $97 per share over the past five years. Its strong performance continues, with a 16.8% increase in the last six months, outperforming the S&P by 13% due to impressive quarterly results.
Boston Scientific Corporation (NYSE:BSX) will participate in the TD Cowen 45th Annual Healthcare Conference on March 4, 2025, at 9:10 AM ET. The company will be represented by Dan Brennan, the Chief Financial Officer, Ken Stein, the Chief Medical Officer, and Art Butcher, the Executive Vice President of MedSurg and APAC. Josh Jennings from the TD Cowen Medical Devices research team will host the event, along with his colleagues Brian Kennedy and Eric Anderson, and they are excited to welcome the Boston Scientific executives.
No matter if you focus on value, growth, or momentum investing, the Zacks Style Scores can help you identify strong stocks more easily. This is one of the key benefits of the Zacks Premium research service.
VCYT remains a focus for investors because of the impressive results from the Afirma and Decipher brands.
Boston Scientific starts 2025 positively, anticipating an organic revenue increase of 14% to 16% in the first quarter.
Boston Scientific's stock (NYSE: BSX) rose by 3% in the five days following its Q4 earnings report last week. The company performed better than expected in both its results and future predictions, but the small increase in stock price might be a result of a large rise in value before the earnings announcement.
On February 10, 2025, BSX, ENVA, and CFR were included in the Zacks Rank #1 (Strong Buy) list of momentum stocks.
This is a comparison of how Boston Scientific (BSX) and Alphatec (ATEC) have done in relation to their industry this year.
Are you looking for ways to choose powerful stocks that can outperform the market for your investment portfolio? The Zacks Style Scores can help you with that.
Boston Scientific Corporation (NYSE:BSX) will hold its Q4 2024 Earnings Conference Call on February 5, 2025, at 8:00 AM ET. Key company participants include Jonathan Monson, Michael Mahoney, Daniel Brennan, and Kenneth Stein. The call will also feature analysts from various financial institutions, and all attendees will be in listen-only mode.